BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31662298)

  • 41. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TAF15-ZNF384 fusion gene in childhood mixed phenotype acute leukemia.
    Yao L; Cen J; Pan J; Liu D; Wang Y; Chen Z; Ruan C; Chen S
    Cancer Genet; 2017 Feb; 211():1-4. PubMed ID: 28279306
    [No Abstract]   [Full Text] [Related]  

  • 43. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential.
    Martin-Padura I; Marighetti P; Gregato G; Agliano A; Malazzi O; Mancuso P; Pruneri G; Viale A; Bertolini F
    Neoplasia; 2012 Nov; 14(11):1057-66. PubMed ID: 23226099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
    Sandahl JD; Coenen EA; Forestier E; Harbott J; Johansson B; Kerndrup G; Adachi S; Auvrignon A; Beverloo HB; Cayuela JM; Chilton L; Fornerod M; de Haas V; Harrison CJ; Inaba H; Kaspers GJ; Liang DC; Locatelli F; Masetti R; Perot C; Raimondi SC; Reinhardt K; Tomizawa D; von Neuhoff N; Zecca M; Zwaan CM; van den Heuvel-Eibrink MM; Hasle H
    Haematologica; 2014 May; 99(5):865-72. PubMed ID: 24441146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemia.
    Walter C; Pozzorini C; Reinhardt K; Geffers R; Xu Z; Reinhardt D; von Neuhoff N; Hanenberg H
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29090521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.
    Pineault N; Abramovich C; Ohta H; Humphries RK
    Mol Cell Biol; 2004 Mar; 24(5):1907-17. PubMed ID: 14966272
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia.
    Lu X; Zhuang H; Yu Q; Zhang X; Wu Z; Zhang L; Xu Y; Wu B; Yang L; Ma A; Gan X; Yu X; Shen J; Xu R
    Exp Cell Res; 2018 Oct; 371(2):409-416. PubMed ID: 30179602
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.
    Dickerson KM; Qu C; Gao Q; Iacobucci I; Gu Z; Yoshihara H; Backhaus EA; Chang Y; Janke LJ; Xu B; Wu G; Papachristou EK; D'Santos CS; Roberts KG; Mullighan CG
    Blood Cancer Discov; 2022 May; 3(3):240-263. PubMed ID: 35247902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
    Bonnet D; Dick JE
    Nat Med; 1997 Jul; 3(7):730-7. PubMed ID: 9212098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
    Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
    Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
    Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
    Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
    Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
    Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming activities of the
    Fisher JN; Thanasopoulou A; Juge S; Tzankov A; Bagger FO; Mendez MA; Peters AHFM; Schwaller J
    Haematologica; 2020 Jul; 105(7):1857-1867. PubMed ID: 31558671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
    Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
    Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
    Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
    Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Sinha R; Porcheri C; d'Altri T; González J; Ruiz-Herguido C; Rabbitts T; Espinosa L; Bigas A
    Exp Hematol; 2020 May; 85():13-19. PubMed ID: 32437911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CTCF: A novel fusion partner of ETO2 in a multiple relapsed acute myeloid leukemia patient.
    Li J; Shen Z; Wang Z; Chao H; Xu Y; Zeng Z; Bian X; Zhang J; Pan J; Miao W; Wu W; Yao L; Chen S; Wen L
    J Leukoc Biol; 2022 May; 111(5):981-987. PubMed ID: 34622967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal.
    Zhao X; Chen A; Yan X; Zhang Y; He F; Hayashi Y; Dong Y; Rao Y; Li B; Conway RM; Maiques-Diaz A; Elf SE; Huang N; Zuber J; Xiao Z; Tse W; Tenen DG; Wang Q; Chen W; Mulloy JC; Nimer SD; Huang G
    Blood; 2014 Mar; 123(11):1729-38. PubMed ID: 24449215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frat2 mediates the oncogenic activation of Rac by MLL fusions.
    Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O
    Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.